72-gene classifier for predicting prognosis of estrogen receptor-positive and node-negative breast cancer patients using formalin-fixed, paraffin-embedded tumor tissues

Clinical Breast Cancer

Volumn 14, Issue 3, 2014, Pages

  Nishio, Minako ^a   Naoi, Yasuto ^a   Tsunashima, Ryo ^a   Nakauchi, Chiaki ^a   Kagara, Naofumi ^a   Shimoda, Masafumi ^a   Shimomura, Atsushi ^a   Maruyama, Naomi ^a   Shimazu, Kenzo ^a   Kim, Seung Jin ^a   Noguchi, Shinzaburo ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

DNA microarray; FFPE; Gene classifier; Gene expression analysis; Prognostic prediction

Indexed keywords

ANASTROZOLE; DNA; FORMALDEHYDE; PARAFFIN; ESTROGEN RECEPTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLASSIFIER; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DNA PROBE; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; GENE EXPRESSION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOW RISK POPULATION; MASTECTOMY; NODE NEGATIVE BREAST CANCER; PARTIAL MASTECTOMY; RECURRENCE FREE SURVIVAL; TUMOR GENE; BIOSYNTHESIS; BREAST TUMOR; CLASSIFICATION; DISEASE FREE SURVIVAL; GENE EXPRESSION PROFILING; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; TISSUE FIXATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FORMALDEHYDE; GENE EXPRESSION PROFILING; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARAFFIN EMBEDDING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, ESTROGEN; TISSUE FIXATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84899939441     PISSN: 15268209     EISSN: 19380666     Source Type: Journal    
DOI: 10.1016/j.clbc.2013.11.006     Document Type: Article

References (26)

1. A. Prat, M.J. Ellis, and C.M. Perou et al. Practical implications of gene-expression-based assays for breast oncologists Nat Rev Clin Oncol 9 2011 48 57
2. A. Prat, and C.M. Perou Deconstructing the molecular portraits of breast cancer Mol Oncol 5 2011 5 23
3. S. Paik Is gene array testing to be considered routine now? Breast 20 suppl 3 2011 S87 S91
4. C.M. Perou, and A.L. Borresen-Dale Systems biology and genomics of breast cancer Cold Spring Harb Perspect 3 2011 pii:a003293
5. C. Kim, and S. Paik Gene-expression-based prognostic assays for breast cancer Nat Rev Clin Oncol 7 2010 340 347
6. J.S. Ross, C. Hatzis, and W.F. Symmans et al. Commercialized multigene predictors of clinical outcome for breast cancer Oncologist 13 2008 477 493
7. P.E. Colombo, F. Milanezi, and B. Weigelt et al. Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction Breast Cancer Res 13 2011 212
8. Y. Gokmen-Polar, and S. Badve Molecular profiling assays in breast cancer: are we ready for prime time? Oncology (Williston Park) 26 2012 350 357 361
9. Y. Naoi, K. Kishi, and T. Tanei et al. Development of 95-gene classifier as a powerful predictor of recurrences in node-negative and ER-positive breast cancer patients Breast Cancer Res Treat 128 2011 633 641
10. Y. Naoi, K. Kishi, and R. Tsunashima et al. Comparison of efficacy of 95-gene and 21-gene classifier (Oncotype DX) for prediction of recurrence in ER-positive and node-negative breast cancer patients Breast Cancer Research and Treatment 140 2013 299 306
11. L. Mittempergher, J.J. de Ronde, and M. Nieuwland et al. Gene expression profiles from formalin fixed paraffin embedded breast cancer tissue are largely comparable to fresh frozen matched tissue PLoS One 6 2011 e17163
12. C.M. Perou, T. Sorlie, and M.B. Eisen et al. Molecular portraits of human breast tumours Nature 406 2000 747 752
13. C. Sotiriou, P. Wirapati, and S. Loi et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis J Natl Cancer Inst 98 2006 262 272
14. L.J. van 't Veer, H. Dai, and M.J. van de Vijver et al. Gene expression profiling predicts clinical outcome of breast cancer Nature 415 2002 530 536
15. M.S. Scicchitano, D.A. Dalmas, and M.A. Bertiaux et al. Preliminary comparison of quantity, quality, and microarray performance of RNA extracted from formalin-fixed, paraffin-embedded, and unfixed frozen tissue samples J Histochem Cytochem 54 2006 1229 1237
16. K.M. Linton, Y. Hey, and E. Saunders et al. Acquisition of biologically relevant gene expression data by Affymetrix microarray analysis of archival formalin-fixed paraffin-embedded tumours Br J Cancer 98 2008 1403 1414
17. S. Lassmann, C. Kreutz, and A. Schoepflin et al. A novel approach for reliable microarray analysis of microdissected tumor cells from formalin-fixed and paraffin-embedded colorectal cancer resection specimens J Mol Med (Berl) 87 2009 211 224
18. K. Morimoto, S.J. Kim, and T. Tanei et al. Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression Cancer Sci 100 2009 1062 1068
19. C.W. Elston, and I.O. Ellis Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 19 1991 403 410
20. R.F. Ward, and S.L. Werner Analysis of Variance of the Composition of a Migmatite Science 140 1963 978 979
21. M. Dowsett, J. Cuzick, and C. Wale et al. Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study J Clin Oncol 28 2010 1829 1834
22. B. Gyorffy, Z. Benke, and A. Lanczky et al. RecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data Breast Cancer Res Treat 132 2012 1025 1034
23. D. Abdueva, M. Wing, and B. Schaub et al. Quantitative expression profiling in formalin-fixed paraffin-embedded samples by Affymetrix microarrays J Mol Diagn 12 2010 409 417
24. S. Paik, S. Shak, and G. Tang et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 351 2004 2817 2826
25. A. Goldhirsch, J.N. Ingle, and R.D. Gelber et al. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009 Ann Oncol 20 2009 1319 1329
26. M.E. Hammond, D.F. Hayes, and M. Dowsett et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version) Arch Pathol Lab Med 134 2010 e48 e72